HCC is a type of liver cancer that originates in the main liver cells ... Further investigations into the biological significance of one of the five key markers in the TIMES system — dubbed SPON2 — ...

Chinese scientists and their Singaporean collaborators have developed a scoring system to predict the risk of recurrence for hepatocellular carcinoma, a serious form of liver cancer, achieving an ...

Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class ...

Tumor marker blood tests may help inform various aspects of cancer care, including diagnosis, staging, treatment planning, and outlook. However, they’re often not the only diagnostic tests used.

However, tumor marker tests aren’t the only tools they’ll use in cancer care. Other testing techniques will help provide a more comprehensive look at your type of cancer. Regular cells may ...

These markers are not to be used as screening parameters for malignant diseases due to low specificity (with the exception of AFP in patients with liver cirrhosis). New tumor markers such as Tumor ...

AI cancer treatment technology researcher, Dr Chandrima Sengupta, is receiving funding from the NSW government.

Atezo/Bev therapy is generally recommended as the first treatment for patients with liver cancer. However, there are no ...

Some liver tumors are categorized as "FLC-like" but lack the fusion protein. Are they actually FLC? And since FLC is ...